The Scientific Instrumentation Facility and its personnel provide three types of services related tolaboratory equipment and facilities to UWCCC investigators. First, it maintains an array of commonlyrequired scientific equipment for shared use at the Clinical Science Center (CSC) in close proximity tothe clinical facilities and the McArdle Laboratory, in close proximity to the nucleus of basic sciencedepartments. The shared equipment includes centrifuges, scintillation counters, phosphorimagers,fluorimagers, Class III biosafety cabinets, ice machines, and water purification units. The facilityprovides support for the purchase of these types of shared equipment, installation, and preventivemaintenance and repair; it also coordinates repair services for all investigator-owned commonlaboratory instruments. Second, it affords access to and training in the use of a BL-3 level containmentfacility located in the McArdle Laboratory that enables UWCCC members to work safely with extremehuman pathogens, such as the Human Immunodeficiency Virus or Hepatitis B Virus. Finally, SIFfacilitates the relocation of personnel or laboratory equipment, coordinates all remodeling projects, andestablishes customized laboratory facilities for new faculty by coordinating with the University PhysicalPlant and Engineering Craft services. This shared resource maintains an inventory of UWCCCequipment and usage, and facilitates the enforcement of UWCCC security, safety, and spacemanagement policies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014520-34
Application #
7491889
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-07-23
Project End
2012-03-31
Budget Start
2007-07-23
Budget End
2008-03-31
Support Year
34
Fiscal Year
2007
Total Cost
$260,475
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
van Ravesteyn, Nicolien T; van den Broek, Jeroen J; Li, Xiaoxue et al. (2018) Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches. Med Decis Making 38:126S-139S
Robins, H Ian; Nguyen, HuyTram N; Field, Aaron et al. (2018) Molecular Evolution of a Glioblastoma Controlled With Tumor Treating Fields and Concomitant Temozolomide. Front Oncol 8:451
Esbona, Karla; Yi, Yanyao; Saha, Sandeep et al. (2018) The Presence of Cyclooxygenase 2, Tumor-Associated Macrophages, and Collagen Alignment as Prognostic Markers for Invasive Breast Carcinoma Patients. Am J Pathol 188:559-573
Hernández-Santos, Nydiaris; Wiesner, Darin L; Fites, J Scott et al. (2018) Lung Epithelial Cells Coordinate Innate Lymphocytes and Immunity against Pulmonary Fungal Infection. Cell Host Microbe 23:511-522.e5
Lyu, Zhigang; Kang, Lei; Buuh, Zakey Yusuf et al. (2018) A Switchable Site-Specific Antibody Conjugate. ACS Chem Biol 13:958-964
Hardin, Heather; Helein, Holly; Meyer, Kristy et al. (2018) Thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of lncRNAs. Lab Invest 98:1133-1142
Pezzi, Hannah M; Niles, David J; Schehr, Jennifer L et al. (2018) Integration of Magnetic Bead-Based Cell Selection into Complex Isolations. ACS Omega 3:3908-3917
Alagoz, Oguzhan; Ergun, Mehmet Ali; Cevik, Mucahit et al. (2018) The University of Wisconsin Breast Cancer Epidemiology Simulation Model: An Update. Med Decis Making 38:99S-111S
Bednarz, Bryan; Grudzinski, Joseph; Marsh, Ian et al. (2018) Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents. Health Phys 114:450-459
Romero-Masters, James C; Ohashi, Makoto; Djavadian, Reza et al. (2018) An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PLoS Pathog 14:e1007221

Showing the most recent 10 out of 1528 publications